Shane White

Durvalumab induced sarcoid-like pulmonary lymphadenopathy

Emma Sanderson, Hari Wimaleswaran, Clare Senko, Shane White, Christine F McDonald

Journal article  |  2020  |  Respirology Case Reports

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable

L Chin-Lenn, RH De Boer, E Segelov, GM Marx, TM Hughes, NJ McCarthy, SC White, SS Foo, JJ Rutovitz, S Della-Fiorentina, R Jennens, YC Antill, D Tsoi, MF Cronk, JM Lombard, BE Kiely, JH Chirgwin, A Gorelik, GB Mann

Journal article  |  2018  |  Asia-Pacific Journal of Clinical Oncology

Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors

Susan R Davis, Penelope J Robinson, Fiona Jane, Shane White, Michelle White, Robin J Bell

Journal article  |  2018  |  The Journal of Clinical Endocrinology & Metabolism

The benefits of adding metformin to tamoxifen to protect the endometrium-A randomized placebo-controlled trial

Susan R Davis, Penelope J Robinson, Fiona Jane, Shane White, Kristy A Brown, Sofie Piessens, Andrew Edwards, Jane McNeilage, Jillian Woinarski, Mitchell Chipman, Robin J Bell

Journal article  |  2018  |  Clinical Endocrinology

Culturally and linguistically diverse oncology patients' perspectives of consultation audio-recordings and question prompt lists

Amelia Hyatt, Ruby Lipson-Smith, Karla Gough, Phyllis Butow, Michael Jefford, Thomas F Hack, Sandra Hale, Emiliano Zucchi, Shane White, Uldis Ozolins, Penelope Schofield

Journal article  |  2018  |  Psycho-Oncology

Exploring disparities in receipt of adjuvant chemotherapy in culturally and linguistically diverse groups: an Australian centre's experience

Alesha A Thai, Mark Tacey, Amanda Byrne, Shane White, Jaclyn Yoong

Journal article  |  2018  |  Internal Medicine Journal

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.

Marco Colleoni, Weixiu Luo, Per Karlsson, Jacquie Chirgwin, Stefan Aebi, Guy Jerusalem, Patrick Neven, Erika Hitre, Marie-Pascale Graas, Edda Simoncini, Claus Kamby, Alastair Thompson, Sibylle Loibl, Joaquín Gavilá, Katsumasa Kuroi, Christian Marth, Bettina Müller, Seamus O'Reilly, Vincenzo Di Lauro, Andrea Gombos, et al.

Journal article  |  2018  |  The Lancet Oncology

BACKGROUND: In animal models of breast cancer, resistance to continuous use of letrozole can be reversed by withdrawal and reintro..

Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice

M Alexander, R Blum, K Burbury, J Coutsouvelis, M Dooley, O Fazil, T Griffiths, H Ismail, S Joshi, N Love, S Opat, P Parente, N Porter, E Ross, J Siderov, P Thomas, S White, S Kirsa, D Rischin

Journal article  |  2017  |  Internal Medicine Journal

Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC

Michael Michael, Shane C White, Ehtesham Abdi, Louise Nott, Phillip Clingan, Allan Zimet, Peter Button, Daniel Gregory, Benjamin Solomon, Alexander Dobrovic, Hongdo Do, Stephen Clarke

Journal article  |  2015  |  Asia-Pacific Journal of Clinical Oncology

Third-Line Chemotherapy in Small-Cell Lung Cancer: An International Analysis

Demetrios Simos, Golmehr Sajjady, Melissa Sergi, Mun Sem Liew, Raffaele Califano, Cheryl Ho, Natasha Leighl, Shane White, Yvonne Summers, William Petrcich, Paul Wheatley-Price

Journal article  |  2014  |  Clinical Lung Cancer